Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Orbimed Private Investments Ix, Lp investment portfolio
Orbimed Private Investments Ix, Lp has made numerous investments in companies such as Verdiva Bio, Ottimo Pharma, and Rathlin Therapeutics within the Biotech sector.
vc
Portfolio
3
Team
0
Portfolio (3)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Ottimo Pharma Limited Ottimo Pharma develops bifunctional, dual‑paratopic antibodies that simultaneously target PD‑1 and VEGFR2 to treat cancer, aiming to extend the lives of patients with malignancies. It is a clinical‑stage biotechnology company focused on advancing these novel immuno‑oncology therapeutics through clinical development. | Healthcare & Life Sciences | Sandwich | Confirmed | 2026-01-21 |
| Rathlin Therapeutics Limited Rathlin Therapeutics Limited conducts research and experimental development in biotechnology, creating therapeutic solutions for the healthcare and pharmaceutical sectors. | BiotechHealth Tech | London | Confirmed | 2025-09-22 |
Backs Similar Companies
Investors who tend to invest in the same sort of companies.
5 more similar investors hiddenSign up to unlock →
Shareholding changes (3)
Orbimed Private Investments Ix, Lp's positions across portfolio companies2026
- SERIES A PREFERRED 16,048,781 → 32,097,561
2025
- SERIES A 6,026,786 → 14,363,839
Articles (1)
- Rathlin Therapeutics secures £5m Series A for biotech development24 Jul 2026Rathlin Therapeutics